August 21, National Quality Forum th St, NW Suite 800 Washington, D.C Re: Colonoscopy Quality Index (NQF# C 2056)

Similar documents
GI Quality Improvement Consortium, Ltd. (GIQuIC) QCDR Non-PQRS Measure Specifications

GIQIC18 Appropriate follow-up interval of not less than 5 years for colonoscopies with findings of 1-2 tubular adenomas < 10 mm

Digestive Health Southwest Endoscopy 2016 Quality Report

Colonoscopy Quality Data 2017

Merit-based Incentive Payment system (MIPS) 2018 Qualified Clinical Data Registry (QCDR) Measure Specifications

Colonoscopy Quality Data

Title Description Type / Priority

Kenneth D. Chi, MD Medical Director, GI Lab Advocate Lutheran General Hospital Center for Digestive Health May 7, 2016

Quality in Endoscopy: Can We Do Better?

Improving Access to Endoscopy at Safety-Net Hospitals. Lukejohn W. Day MD Assistant Professor of Medicine

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Measure #425: Photodocumentation of Cecal Intubation National Quality Strategy Domain: Effective Clinical Care

Screening for Colorectal Cancer in the Elderly. The Broad Perspective

Choice of sedation and its impact on adenoma detection rate in screening colonoscopies

Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem

AMERICAN GASTROENTEROLOGICAL ASSOCIATION DIGESTIVE HEALTH RECOGNITION PROGRAM IN COLLABORATION WITH CECITY. Non-PQRS Narrative Measure Specifications

Technology and Interventions to Improve ADR

2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process

Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer

Colon Polyps: Detection, Inspection and Characteristics

Variation in Detection of Adenomas and Polyps by Colonoscopy and Change Over Time With a Performance Improvement Program

Measure #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clincal Care

2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Screening & Surveillance Guidelines

PQRS/QCDR/VBPM/GIQuIC -- Making $ense of All the Letters

Quality ID #343: Screening Colonoscopy Adenoma Detection Rate National Quality Strategy Domain: Effective Clinical Care

Research Article Development of Polyps and Cancer in Patients with a Negative Colonoscopy: A Follow-Up Study of More Than 20 Years

Tips to Improve ADRs during Colonoscopy

Retroflexion and prevention of right-sided colon cancer following colonoscopy: How I approach it

Increasing the number of older persons in the United

Quality Measures In Colonoscopy: Why Should I Care?

Supplementary Appendix

Benchmarking For Colonoscopy. Technology and Technique to Improve Adenoma Detection

Early detection and screening for colorectal neoplasia

Circumstances in which colonoscopy misses cancer

Colorectal Cancer Screening: A Clinical Update

Colorectal cancer is the second leading cause of cancer-related. Colonoscopic Miss Rates for Right-Sided Colon Cancer: A Population-Based Analysis

ASGE and AGA Issue Consensus Statement on Surveillance and Management of Dysplasia in Patients With Inflammatory Bowel Disease

11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist

When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool

2/14/2018 CODING PITFALLS IN THE ASC AVERAGE RISK VS HIGH RISK SCREENING TOP CODING PITFALLS

The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?

Predicting Colonoscopy Time: A Quality Improvement Initiative

Implementation of a program to improve the quality of colonoscopy increases the neoplasia detection rate: a prospective study

Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative

Objectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background

Risk Factors for Recurrent High-Risk Polyps after the Removal of High-Risk Polyps at Initial Colonoscopy

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Outcome High Priority

General and Colonoscopy Data Collection Form

Latest Endoscopic Guidelines for FAP, HNPCC, IBD, and the General Population

Devices To Improve Colon Polyp Detection

Measuring the quality of colonoscopy: Where are we now and where are we going?

SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE

Colon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011

Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy

Colon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership

ACG Clinical Guideline: Colorectal Cancer Screening

Quality Outcomes for Endoscopy

RE: Proposed Decision Memo for Screening for Hepatitis C Virus (HCV) in Adults (CAG-00436N)

Appendix 1 (as supplied by the authors): Supplementary tables. Supplementary Table A1. Description of OHIP codes used in the current study.

Colorectal Cancer Screening

CRC Risk Factors. U.S. Adherence Rates Cancer Screening. Genetic Model of Colorectal Cancer. Epidemiology and Clinical Consequences of CRC

Screening for Colon Cancer: How best and how effective? Richard Rosenberg, MD Assistant Professor of Medicine Columbia University Medical Center

Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005

Supporting Information 2. ESGE QIC Lower GI Delphi voting process: Round 1 Working Group chair: Michal F. Kaminski, Poland

The Use of Quality Measures in Colorectal Cancer Screening

The Canadian Cancer Society estimates that in

Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines

Performance targets for lesion detection in surveillance

Barrett s esophagus. Barrett s neoplasia treatment trends

Colorectal Cancer Prevention Quantity and Quality Count

The Prevalence Rate and Anatomic Location of Colorectal Adenoma and Cancer Detected by Colonoscopy in Average-Risk Individuals Aged Years

Monitoring of colonoscopy quality indicators in an academic endoscopy facility reveals adherence to international recommendations

GI Coding Updates. Rhonda Buckholtz, CPC, CPCI, CPMS, CRC, CDEO, CHPSE, CGSC, COBGC, CENTC, CPEDC

Is the level of cleanliness using segmental Boston bowel preparation scale associated with a higher adenoma detection rate?

MERIT-BASED INCENTIVE PAYMENT SYSTEM (MIPS) QUALITY CATEGORY

Colorectal Cancer Screening And Related Ancillary Services

EXPERT WORKING GROUP Surveillance after neoplasia removal. Meeting Chicago, May 5th 2017 Chair: Rodrigo Jover Uri Ladabaum

Summary. Cezary ŁozińskiABDF, Witold KyclerABCDEF. Rep Pract Oncol Radiother, 2007; 12(4):

Improving Your Adenoma Detection Rate

COLON CANCER SCREENING: AN UPDATE

With CRC Screening Rates on the Rise, Quality Control Becomes Center of Attention

Quality ID #439: Age Appropriate Screening Colonoscopy National Quality Strategy Domain: Efficiency and Cost Reduction

C olorectal adenomas are reputed to be precancerous

removal of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2

Endocuff assisted colonoscopy significantly increases sessile serrated adenoma detection in veterans

DIGESTIVE SYSTEM SURGICAL PROCEDURES May 1, 2015 INTESTINES (EXCEPT RECTUM) Asst Surg Anae

NATIONAL QUALITY FORUM

An Updated Approach to Colon Cancer Screening and Prevention

Research Article Adenoma and Polyp Detection Rates in Colonoscopy according to Indication

Variable Endoscopist performance in proximal and distal adenoma detection during colonoscopy: a retrospective cohort study

Improving the quality of endoscopic polypectomy by introducing a colonoscopy quality assurance program

Frequency of Diagnosis of Colorectal Cancer with Double Contrast Barium Enema

Quality Indicators in Colonoscopy

CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD

Do any benign polyps require an operation?

Colonoscopic Screening of Average-Risk Women for Colorectal Neoplasia

Improving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)

Transcription:

August 21, 2012 National Quality Forum 1030 15th St, NW Suite 800 Washington, D.C. 20005 Re: Colonoscopy Quality Index (NQF# C 2056) The American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), and American Society for Gastrointestinal Endoscopy (ASGE) welcome the opportunity to comment on the National Quality Forum (NQF) Gastrointestinal/Genitourinary Measure Concepts. Together, our three societies represent virtually all practicing gastroenterologists in the United States. We appreciate that the NQF has included gastrointestinal measures in its pilot of the redesigned twostage process. Our societies have been involved in the development of many of the measures being presented to the Gastrointestinal/Genitourinary Steering Committee and look forward to participating in their discussions later this month. We would like to take this opportunity to comment on the Colonoscopy Quality Index composite measure submitted by Quality Quest for Health of Illinois. The submitting organization proposes a composite measure that requires the reporting physician to meet all quality parameters, namely the following elements 1 : Appropriate indication Complete exam Photo-documentation of the cecum No serious acute complications Cardiac risk assessment Bowel preparation assessment (excellent/good/fair/poor/unsatisfactory) Polyp information complete or no polyp (#/size/location/morph/removal/method) Withdrawal time recorded Appropriate follow-up recommendation Our societies have great concern that this measure was developed without input from the specialty societies that perform this procedure the gastroenterology societies (ACG, ASGE or AGA), surgical societies (American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons, American Society of Colon and Rectal Surgeons) and primary care societies (American Academy of Family Physicians, American College of Physicians, American Osteopathic Association). As we describe below, several of the proposed measurements have not been shown to be associated with an improvement in procedural performance or health outcomes. 1 Lieberman D, Nadel M, Smith R, et al: Standardized colonoscopy reporting and data system (CO-RADS): Report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007; 65:757-766 1

Our societies strongly support the concept of measuring colonoscopy performance and identifying highquality colonoscopies. The proper preparation of the patient and performance of colonoscopy to ensure a high-quality examination, accompanied by recommendations based on findings from a high-quality examination, can diminish risks to patients, avoid the need for unnecessary interval examinations, and improve continuity of care. The collective efforts of our societies to develop the PCPI/AGA/ASGE 2008 PCPI Endoscopy and Polyp Surveillance Measure Set and a recent colonoscopy composite measure submitted by the ACG, AGA, and ASGE to the Centers for Medicare and Medicaid Services (CMS) for the Physician Quality Reporting System (PQRS) 2014 reflect that commitment. The elements of our proposed composite measure are: Documentation of assessment of bowel preparation Photodocumentation of completeness of colonoscopy including cecal intubation or ileocolonic anastomosis. The three GI societies carefully reviewed each of the elements in this composite measure from Quality Quest and found a lack of evidence for several of the elements. In view of such, we determined that it would not be appropriate to include them in the composite measure that we submitted to CMS. We plan to continue the development of that measure, including a public comment period, over the coming months. We are concerned that the proposed measure is extremely complicated to implement, limiting its usability and feasibility by practices, small or large, community or academic, gastroenterologist, internist, family practitioner or surgeon. The AGA, which sponsors the AGA Digestive Health Outcomes Registry, has met with Quality Quest and determined that it would be extremely difficult for practices to report the proposed data from this measure into a registry. Our specific comments on the elements of the measure follow. 1. Appropriate indication for colonoscopy For over 20 years, the American Society for Gastrointestinal Endoscopy 2 has published standards of practice on the appropriate use of colonoscopy and other endoscopic procedures, which have been incorporated into coverage determinations from Medicare contractors 3 and commercial payors 4. Our societies fail to see the improvement in health outcomes that would result from an exercise in documentation that is more appropriately characterized as a utilization management determination. 2. Standardized medical risk assessment In the 2008 PCPI Endoscopy and Polyp Surveillance Measure Set the evidence for this element as part of the Comprehensive Colonoscopy Documentation measure was Grade 1C (intermediate-strength recommendation; may change when stronger evidence is available).we are not aware of any new evidence in the past four years which would change this recommendation. 3. Cardiac risk assessment Several studies have noted a shift in the performance of colonoscopy where the provision of sedation is increasingly being provided by anesthesia professionals. 56 It would be inappropriate to include cardiac risk assessment that is provided by a different health professional within a colonoscopy composite measure for the endoscopist. 2 Early DS, Ben-Menachem T, Decker GA, et al. Appropriate use of GI Endoscopy. A consensus statement from the American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 2012; 75: 1127-31 3 Wisconsin Physicians Service Local Coverage Determination L30304 GI-006 Colonoscopy and Sigmoidoscopy Diagnostic. Effective date 07/16/2012 4 Empire BlueCross BlueShield Clinical UM Guideline CG-SURG-01 Colonoscopy. Effective date 07/10/2012. 5 Liu H, Waxman DA, Main R, Mattke S. Utilization of Anesthesia Services During Outpatient Endoscopies and Colonoscopies and Associated Spending in 2003-2009. JAMA. 2012;307(11):1178-1184. 6 Inadomi JM, Gunnarsson CL, Rizzo JA, et al. Projected increased growth rate of anesthesia professional-delivered sedation for colonoscopy and EGD in the United States: 2009 to 2015. Gastrointest Endosc. 2010;72(3):580-586 2

4. Assessment of bowel preparation Poor bowel preparation is a major impediment to the effectiveness of colonoscopy, affects the ability to detect polyps, and influences the timing of repeat examinations. Given the increased premalignant potential of advanced adenomas, suboptimal bowel preparation may cause an unacceptably high failure rate at identifying these important lesions, thereby compromising the effectiveness of the colonoscopy. Adenoma miss rates in the context of suboptimal bowel preparation are as high as 42%. 7 To decrease the risk of missed lesions when the bowel is poorly prepared, a follow-up or repeat colonoscopy should be recommended at a significantly shorter interval than if the bowel was well prepared. Current literature shows great variability in recommendations for follow-up in this circumstance, presenting an opportunity for improvement. Although there is relative uniformity in surveillance intervals when bowel preparation is optimal, there is considerable variability when bowel preparation is suboptimal. 8 9 In view of the opportunity for improvement and the desire to ensure a high-quality colonoscopy, the ACG, AGA, and ASGE are supportive of an element on Documentation of Assessment of Bowel Preparation. In our submission to CMS for PQRS 2014, we saw the need to include this element as part of a Colonoscopy Quality Composite measure. 5. Complete examination Based on element six (6) below this seems redundant. 6. Cecal photo taken While the definition of a colonoscopy is examination of the colon proximal to the splenic flexure, a high-quality evaluation of the colon consists of examination of the entire colon from the rectum to the cecum or ileo-colonic anastomosis. A significant fraction of colonic neoplasms are located in the right colon, hence successful cecal intubation should be specifically noted with recommended cecal intubation rates of 95% in healthy adults. 10 11 Knowing the completeness of the examination can inform physicians whether an imaging procedure or repeat colonoscopy is necessary, and influences the timing of follow-up examination Our societies are supportive of an element on Photodocumentation of Completeness of Colonoscopy including cecal intubation or ileocolonic anastomosis. In our submission to CMS for PQRS 2014, we saw the need to include this element as part of a Colonoscopy Quality Composite measure. 7. All essential polyp information recorded (including size, morphology, location, method of removal) This measure is an important process measure that for purposes of quality improvement at the individual endoscopist and practice level. However, we question its strength as an accountability measure. 8. Withdrawal time recorded Despite the positive correlation between withdrawal times and detection of adenomatous lesions 12 withdrawal times fail to correlate with 5-year interval neoplasia 13 and withdrawal time 7 Chokshi RV, Hovis CE, Hollander T, et al. Prevalence of missed adenomas in patients with inadequate bowel preparation on screening colonoscopy. Gastrointest Endosc 2012;75:1197-203 8 Ben-Horin S, Bar-Meir S, Avidan B. The impact of colon cleanliness assessment on endoscopists recommendations for follow-up colonoscopy. Am J Gastroenterol 2007;102:2680-5 9 Lebwohl B, Kastrinos F, Glick M, et al. The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc 2011;73:1207-14. 10 Imperiale TF, Wagner DR, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343(3): 169-74. 11 Rabeneck, L, Rumble RB, et al. Cancer Care Ontario Colonoscopy Standards: standards and evidentiary base. Can J Gastroenterol 2007; 21 Suppl D: 5D-24D. 12 Barclay RL, Vicari JJ, Doughty AS, et al. Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy. N Engl J Med 2006; 355:2533-2541) 13 Gellad, ZF, Weiss DG, et al. Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol 2010; 105(8): 1746-52 3

can be reduced safely with the use of wide angle endoscopes. 14 The expert panel that reviewed these measures determined there was a significant potential that this measure could be gamed without any appreciable improvement in polyp detection or outcomes. 9. Free of serious complication While complications such as perforation or bleeding following the procedure should be monitored and documented to allow identification and correction of any systematic errors, the rate of complications is quite uncommon 15. Attribution of the delayed complications to individual endoscopists may be difficult as such patients may present to health care facilities with which the endoscopists is not associated. 10. Appropriate follow-up recommendation Endoscopists should adhere to the recommended surveillance guidelines post-resection or postpolypectomy, which make the assumption of cecal intubation, adequate bowel preparation and careful examination. Now that CMS has included PQRS measures for prospective surveillance interval after a normal screening examination and retrospective interval for those with adenomatous polyps 16, including such within a colonoscopy composite measure would be duplicative. The measure developer has interpreted the recommendations for appropriate follow-up indications for colonoscopy and surveillance colonoscopy in an incorrect manner. According to the measure developer, proper follow-up indications would be based upon a finding of adenomas or neoplasia greater than 1 centimeter (cm). In fact, the authors made recommendations on the appropriate follow-up on patients with finding of adenomas or neoplasia greater than or equal to 1 cm. 17 In conclusion, the ACG, AGA, and ASGE believe that the composite measure proposed by Quality Quest for Health of Illinois requires the collection of data elements that, in total, have not been shown to lead to the identification of a high-quality colonoscopy, improvement in health outcomes, or reduction of waste and unnecessary procedures. In comparison, the composite measure proposed by our societies to CMS for incorporation in PQRS 2014 - Documentation of Assessment of Bowel Preparation and Photodocumentation of Completeness of Colonoscopy including cecal intubation or ileocolonic anastomosis achieves the goals of allowing the physician, patient, purchaser and payor to identify a high-quality colonoscopy and, when deficiencies are seen, providing a pathway for remediation and quality improvement. Our organizations appreciate the opportunity to provide our comments on the Colonoscopy Quality Index composite measure. Any questions or requests for more information can be directed to Debbie Robin, Senior Director for Quality, AGA, at drobin@gastro.org or 301-941-2615; Brad Conway, Vice, Public Policy, ACG, at bconway@gi.org or 301-263-9000; or Eden Essex, Quality and Health Policy Manager, ASGE, at eessex@asge.org or 630-570-5646. Sincerely, 14 Deenadayalu, VP, Chadalawada V, et al. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates. Am J Gastroenterol 2004; 99(11): 2138-42. 15 Ko CW, Riffle S, et al. Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 2010; 8(2): 166-73. 16 CMS-1590-P: Revisions to Payment Policies Under the Physician Fee Schedule and Other Revisions to Medicare Part B for CY 2013 (Including DME Face-to-Face & Non-random Prepayment Review) Publication Date: July 30, 2012 17 Lieberman D, Nadel M, Smith R, et al: Standardized colonoscopy reporting and data system (CO-RADS): Report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc 2007; 65:757-766 4

Lawrence R. Schiller, MD, FACG American College of Gastroenterology Loren Laine, MD, AGAF American Gastroenterological Association Thomas M. Deas, Jr., MD, MMM, FASGE American Society for Gastrointestinal Endoscopy 5